{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:23:34Z","timestamp":1791933814150,"version":"4.3.4"},"reference-count":114,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.idc.2025.01.002","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T10:38:40Z","timestamp":1743417520000},"page":"e33-e60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"S","title":["Invasive Aspergillosis in the Current Era"],"prefix":"10.1016","volume":"39","author":[{"given":"Sabina","family":"Herrera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Magyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahid","family":"Husain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.idc.2025.01.002_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00140-18","article-title":"Aspergillus fumigatus and aspergillosis in 2019","volume":"33","author":"Latg\u00e9","year":"2019","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"10.1016\/j.idc.2025.01.002_bib2","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.cmi.2016.05.013","article-title":"Previously unknown species of Aspergillus","volume":"22","author":"Gautier","year":"2016","journal-title":"Clin Microbiol Infection"},{"issue":"8","key":"10.1016\/j.idc.2025.01.002_bib10","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the transplant- associated infection surveillance network (TRANSNET) database","volume":"50","author":"Kontoyiennis","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2025.01.002_bib17","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the transplant-associated infection surveillance network (Transnet)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2025.01.002_bib18","doi-asserted-by":"crossref","first-page":"e12898","DOI":"10.1111\/tid.12898","article-title":"Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study","volume":"20","author":"Neofytos","year":"2018","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2025.01.002_bib25","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/myc.13410","article-title":"Incidence, risk factors and mortality of invasive pulmonary aspergillosis in patients with influenza: a systematic review and meta-analysis","volume":"65","author":"Shi","year":"2022","journal-title":"Mycoses"},{"issue":"2","key":"10.1016\/j.idc.2025.01.002_bib108","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S2213-2600(21)00442-2","article-title":"Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study","volume":"10","author":"Gangneux","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.idc.2025.01.002_bib24","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.chest.2023.09.019","article-title":"Prevalence, risk factors, clinical features, and outcome of influenza-associated pulmonary aspergillosis in critically ill patients: a systematic review and meta-analysis","volume":"165","author":"Lu","year":"2024","journal-title":"Chest"},{"key":"10.1016\/j.idc.2025.01.002_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2022.01.027","article-title":"Defining COVID-19eassociated pulmonary aspergillosis: systematic review and meta-analysis","author":"Kariyawasam","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.idc.2025.01.002_bib29","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cmi.2021.08.014","article-title":"Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients\u2014a multinational observational study by the European Confederation of Medical Mycology","volume":"28","author":"Prattes","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.idc.2025.01.002_bib22","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of cancer and the mycoses study group education and research consortium","volume":"71","author":"Peter Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2025.01.002_bib109","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.healun.2018.06.008","article-title":"Clinical risk factors for invasive aspergillosis in lung transplant recipients: results of an international cohort study","volume":"37","author":"Aguilar","year":"2018","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"2","key":"10.1016\/j.idc.2025.01.002_bib110","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.healun.2021.09.014","article-title":"Risk factors of invasive fungal infections in lung transplant recipients: a systematic review and meta-analysis","volume":"41","author":"Phoompoung","year":"2022","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"9","key":"10.1016\/j.idc.2025.01.002_bib111","doi-asserted-by":"crossref","first-page":"e13544","DOI":"10.1111\/ctr.13544","article-title":"Invasive aspergillosis in solid-organ transplant recipients: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Husain","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.idc.2025.01.002_bib112","article-title":"Risk factors for COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis","author":"Husain","year":"2024","journal-title":"Lancet Respir Med"},{"issue":"7","key":"10.1016\/j.idc.2025.01.002_bib33","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1469-0691.2009.03015.x","article-title":"Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome","volume":"16","author":"Guinea","year":"2010","journal-title":"Clin Microbiol Infection"},{"issue":"1","key":"10.1016\/j.idc.2025.01.002_bib34","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-015-1140-1","article-title":"Putative invasive pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary disease: a matched cohort study","volume":"19","author":"Delsuc","year":"2015","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.idc.2025.01.002_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1086\/509917","article-title":"Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign","volume":"44","author":"Greene","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"90","key":"10.1016\/j.idc.2025.01.002_bib113","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clinimag.2022.07.003","article-title":"CT findings of COVID-19-associated pulmonary aspergillosis: a systematic review and individual patient data analysis","author":"Hong","year":"2022","journal-title":"Clin Imag"},{"issue":"2","key":"10.1016\/j.idc.2025.01.002_bib36","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/crj.12551","article-title":"Values of radiological examinations for the diagnosis and prognosis of invasive bronchial-pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary diseases","volume":"12","author":"Huang","year":"2018","journal-title":"Clin Respir J"},{"key":"10.1016\/j.idc.2025.01.002_bib9","first-page":"453","article-title":"Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry","volume":"65","author":"Steinbach","year":"2012","journal-title":"J\u00a0Infect"},{"issue":"6","key":"10.1016\/j.idc.2025.01.002_bib11","first-page":"550","article-title":"The burden of Invasive Aspergillosis in patients with haematological malignancy: a meta-analysis and systematic review","volume":"76","author":"van de Peppel","year":"2018","journal-title":"J\u00a0Infect"},{"issue":"1","key":"10.1016\/j.idc.2025.01.002_bib114","doi-asserted-by":"crossref","first-page":"e13200","DOI":"10.1111\/tid.13200","article-title":"Outcomes of solid organ transplant recipients with invasive aspergillosis and other mold infections","volume":"22","author":"Farges","year":"2020","journal-title":"Transpl Infect Dis"},{"issue":"191","key":"10.1016\/j.idc.2025.01.002_bib32","doi-asserted-by":"crossref","first-page":"106720","DOI":"10.1016\/j.rmed.2021.106720","article-title":"Mortality outcomes associated with invasive aspergillosis among acute exacerbation of chronic obstructive pulmonary disease patient population","author":"Mir","year":"2022","journal-title":"Respir Med"},{"key":"10.1016\/j.idc.2025.01.002_bib3","article-title":"Immunopathogenesis of aspergillosis. in: the genus aspergillus - pathogenicity, mycotoxin production and industrial applications","author":"Singh","year":"2022","journal-title":"IntechOpen"},{"issue":"1","key":"10.1016\/j.idc.2025.01.002_bib4","first-page":"81","article-title":"Pulmonary immune responses against Aspergillus fumigatus are characterized by high frequencies of IL-17 producing T-cells","volume":"74","author":"Jolink","year":"2017","journal-title":"J\u00a0Infect"},{"issue":"4","key":"10.1016\/j.idc.2025.01.002_bib5","first-page":"55","article-title":"The multifaceted role of t-helper responses in host defense against aspergillus fumigatus","volume":"3","author":"Dewi","year":"2017","journal-title":"J\u00a0Fungi"},{"issue":"5","key":"10.1016\/j.idc.2025.01.002_bib6","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/eji.200323790","article-title":"A\u00a0role for antibodies in the generation of memory antifungal immunity","volume":"33","author":"Montagnoli","year":"2003","journal-title":"Eur J Immunol"},{"issue":"Supplement_2","key":"10.1016\/j.idc.2025.01.002_bib7","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.1093\/mmy\/myy076","article-title":"Pathophysiological aspects of Aspergillus colonization in disease","volume":"57","author":"Gago","year":"2019","journal-title":"Med Mycol"},{"issue":"7","key":"10.1016\/j.idc.2025.01.002_bib8","doi-asserted-by":"crossref","first-page":"971","DOI":"10.4049\/jimmunol.2400021","article-title":"Glucocorticoids suppress NF-\u03baB\u2013Mediated neutrophil control of Aspergillus fumigatus hyphal growth","volume":"213","author":"Thrikawala","year":"2024","journal-title":"J\u00a0Immunol"},{"issue":"11","key":"10.1016\/j.idc.2025.01.002_bib12","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.3324\/haematol.2011.044636","article-title":"Invasive aspergillosis in patients with hematologic malignancies: incidence and description of 127 cases enrolled in a single institution prospective survey from 2004 to 2009","volume":"96","author":"Nicolle","year":"2009","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.idc.2025.01.002_bib13","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/505870","article-title":"Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey","volume":"43","author":"Cornillet","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2025.01.002_bib14","article-title":"Clinical infectious diseases guidance on imaging for invasive pulmonary aspergillosis and mucormycosis: from the imaging working group for the revision and update of the consensus definitions of fungal Disease from the EORTC\/MSGERC","author":"Baddley","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2025.01.002_bib16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1399-3062.2010.00499.x","article-title":"Clinical and radiological features of invasive pulmonary aspergillosis in transplant recipients and neutropenic patients","volume":"12","author":"Park","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.idc.2025.01.002_bib19","first-page":"269","article-title":"Epidemiological features of invasive mold infections among solid organ transplant recipients: PATH Alliance R registry analysis","volume":"55","author":"Husain","year":"2017","journal-title":"Med Mycol"},{"issue":"1","key":"10.1016\/j.idc.2025.01.002_bib20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1378\/chest.119.1.169","article-title":"Spectrum of Aspergillus infection in lung transplant recipients\u2217 case series and review of the literature","volume":"119","author":"Mehrad","year":"2001","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.idc.2025.01.002_bib21","first-page":"261","article-title":"Aspergillus tracheobronchitis: report of 8 cases and review of the literature","volume":"91","author":"Fern\u00e1ndez-Ruiz","year":"2012","journal-title":"Medicine (United States)"},{"issue":"4","key":"10.1016\/j.idc.2025.01.002_bib23","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00134-024-07341-7","article-title":"Invasive fungal diseases in adult patients in intensive care unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM","volume":"50","author":"Bassetti","year":"2024","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.idc.2025.01.002_bib26","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Articles Lancet Respir Med"},{"issue":"11","key":"10.1016\/j.idc.2025.01.002_bib28","doi-asserted-by":"crossref","first-page":"E3606","DOI":"10.1093\/cid\/ciaa1065","article-title":"Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study","volume":"73","author":"Bartoletti","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2025.01.002_bib30","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idc.2025.01.002_bib35","first-page":"403","article-title":"Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: a case control study from China","volume":"18","author":"Xu","year":"2012","journal-title":"European Society of Clinical Infectious Diseases"},{"issue":"5","key":"10.1016\/j.idc.2025.01.002_bib37","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/lary.23912","article-title":"Survival outcomes in acute invasive fungal sinusitis: a systematic review and quantitative synthesis of published evidence","volume":"123","author":"Turner","year":"2013","journal-title":"Laryngoscope"},{"key":"10.1016\/j.idc.2025.01.002_bib38","author":"Lin"},{"issue":"6","key":"10.1016\/j.idc.2025.01.002_bib39","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2025.01.002_bib40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","article-title":"A\u00a0clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients","volume":"186","author":"Blot","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.idc.2025.01.002_bib41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13613-021-00827-3","article-title":"New clinical algorithm including fungal biomarkers to better diagnose probable invasive pulmonary aspergillosis in ICU","volume":"11","author":"Hamam","year":"2021","journal-title":"Ann Intensive Care"},{"issue":"8","key":"10.1016\/j.idc.2025.01.002_bib42","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s00134-020-06091-6","article-title":"Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion","volume":"46","author":"Verweij","year":"2020","journal-title":"Intensive Care Med"},{"issue":"8","key":"10.1016\/j.idc.2025.01.002_bib43","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001\u20132006: overview of the transplant-associated infection surveillance network (TRANSNET) database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2025.01.002_bib44","first-page":"9","article-title":"Current state of the diagnosis of invasive pulmonary aspergillosis in lung transplantation","author":"Herrera","year":"2019","journal-title":"Front Microbiol"},{"issue":"6","key":"10.1016\/j.idc.2025.01.002_bib45","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/bmt.2011.178","article-title":"ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients","volume":"47","author":"Marchetti","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.idc.2025.01.002_bib46","first-page":"1913","article-title":"Diagnostic value of bronchoalveolar lavage fluid galactomannan assay for invasive pulmonary aspergillosis in adults: a meta-analysis","volume":"47","author":"Li","year":"2022","journal-title":"J\u00a0Clin Pharm Therapeut"},{"issue":"9","key":"10.1016\/j.idc.2025.01.002_bib47","article-title":"Galactomannan detection for invasive aspergillosis in immunocompromised patients","volume":"2017","author":"Leeflang","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1016\/j.idc.2025.01.002_bib48","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1097\/TP.0000000000003187","article-title":"Late onset invasive pulmonary aspergillosis in lung transplant recipients in the setting of a targeted prophylaxis\/preemptive antifungal therapy strategy","volume":"104","author":"Herrera","year":"2020","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.idc.2025.01.002_bib50","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/503427","article-title":"Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis","volume":"42","author":"Pfeiffer","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2025.01.002_bib51","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1378\/chest.10-0488","article-title":"Accuracy of BAL galactomannan in diagnosing invasive aspergillosis","volume":"138","author":"Guo","year":"2010","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.idc.2025.01.002_bib52","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1128\/JCM.00077-07","article-title":"Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients","volume":"45","author":"Clancy","year":"2007","journal-title":"J\u00a0Clin Microbiol"},{"issue":"11","key":"10.1016\/j.idc.2025.01.002_bib53","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1128\/JCM.00942-12","article-title":"Diagnostic accuracy of PCR alone compared to galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis: a systematic review","volume":"50","author":"Avni","year":"2012","journal-title":"J\u00a0Clin Microbiol"},{"issue":"6","key":"10.1016\/j.idc.2025.01.002_bib54","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/cid\/ciq206","article-title":"-D-Glucan assay for the diagnosis of invasive fungal infections: a meta-analysis","volume":"52","author":"Karageorgopoulos","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2025.01.002_bib55","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/cid\/cir897","article-title":"Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3)","volume":"54","author":"Lamoth","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2025.01.002_bib67","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1099\/jmm.0.000092","article-title":"Diagnostic accuracy of a novel lateral-flow device in invasive aspergillosis: a meta-analysis","volume":"64","author":"Pan","year":"2015","journal-title":"J\u00a0Med Microbiol"},{"issue":"6","key":"10.1016\/j.idc.2025.01.002_bib115","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s15010-013-0472-5","article-title":"Comparison of a novel Aspergillus lateral-flow device and the Platelia\u00ae galactomannan assay for the diagnosis of invasive aspergillosis following haematopoietic stem cell transplantation","volume":"41","author":"Held","year":"2013","journal-title":"Infection"},{"issue":"5","key":"10.1016\/j.idc.2025.01.002_bib116","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1128\/JCM.03189-12","article-title":"Evaluation of real-time PCR, galactomannan enzyme-linked immunosorbent assay (ELISA), and a novel lateral-flow device for diagnosis of invasive aspergillosis","volume":"51","author":"White","year":"2013","journal-title":"J\u00a0Clin Microbiol"},{"issue":"8","key":"10.1016\/j.idc.2025.01.002_bib66","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1097\/TP.0000000000000153","article-title":"Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis in solid organ transplant patients","volume":"98","author":"Willinger","year":"2014","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.idc.2025.01.002_bib56","first-page":"967","article-title":"An overview of systematic reviews of polymerase chain reaction (PCR) for the diagnosis of invasive aspergillosis in immunocompromised people: a report of the fungal PCR Initiative (FPCRI)\u2014an ISHAM Working Group","volume":"9","author":"Cruciani","year":"2023","journal-title":"J\u00a0Fungi"},{"issue":"4","key":"10.1016\/j.idc.2025.01.002_bib70","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/infdis\/jiad213","article-title":"Utility of plasma microbial cell-free DNA whole-genome sequencing for diagnosis of invasive aspergillosis in patients with hematologic malignancy or COVID-19","volume":"228","author":"Lee","year":"2023","journal-title":"J\u00a0Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2025.01.002_bib71","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae252","article-title":"Diagnostic value of microbial cell-free DNA sequencing for suspected invasive fungal infections: a retrospective multicenter cohort study","volume":"11","author":"Huygens","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.idc.2025.01.002_bib60","first-page":"13","article-title":"Metagenomic next-generation sequencing for detecting Aspergillosis pneumonia in immunocompromised patients: a retrospective study","author":"Shi","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"10.1016\/j.idc.2025.01.002_bib62","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s15010-017-1072-6","article-title":"Diagnosing filamentous fungal infections in immunocompromised patients applying computed tomography-guided percutaneous lung biopsies: a 12-year experience","volume":"45","author":"Lass-Fl\u00f6rl","year":"2017","journal-title":"Infection"},{"issue":"10","key":"10.1016\/j.idc.2025.01.002_bib57","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.cmi.2016.06.021","volume":"22","author":"Boch","year":"2016","journal-title":"Clin Microbiol Infection"},{"issue":"12","key":"10.1016\/j.idc.2025.01.002_bib58","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/myc.12424","article-title":"Identification of invasive fungal diseases in immunocompromised patients by combining an Aspergillus specific PCR with a multifungal DNA -microarray from primary clinical samples","volume":"58","author":"Boch","year":"2015","journal-title":"Mycoses"},{"key":"10.1016\/j.idc.2025.01.002_bib59","first-page":"13","article-title":"Diagnostic efficacy of metagenomic next generation sequencing in bronchoalveolar lavage fluid for proven invasive pulmonary aspergillosis","author":"Jia","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/j.idc.2025.01.002_bib61","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejrad.2013.03.026","article-title":"High-resolution computed tomographic findings of Aspergillus infection in lung transplant patients","volume":"83","author":"Gazzoni","year":"2014","journal-title":"Eur J Radiol"},{"issue":"7","key":"10.1016\/j.idc.2025.01.002_bib63","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/thx.2010.155515","article-title":"Pulmonary aspergillosis: an alternative diagnosis to lung cancer after positive [18F]FDG positron emission tomography","volume":"66","author":"Baxter","year":"2011","journal-title":"Thorax"},{"issue":"14","key":"10.1016\/j.idc.2025.01.002_bib64","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.7150\/thno.20919","article-title":"Towards translational immunoPET\/MR imaging of invasive pulmonary aspergillosis: the humanised monoclonal antibody JF5 detects Aspergillus lung infections in\u00a0vivo","volume":"7","author":"Davies","year":"2017","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.idc.2025.01.002_bib65","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12281-017-0275-8","article-title":"Lateral flow assays for the diagnosis of invasive aspergillosis: current status","volume":"11","author":"Heldt","year":"2017","journal-title":"Curr Fungal Infect Rep"},{"key":"10.1016\/j.idc.2025.01.002_bib68","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.12688\/f1000research.19766.4","article-title":"Next-generation sequencing of microbial cell-free DNA for rapid noninvasive diagnosis of infectious diseases in immunocompromised hosts","volume":"8","author":"Camargo","year":"2020","journal-title":"F1000Res"},{"issue":"11","key":"10.1016\/j.idc.2025.01.002_bib69","doi-asserted-by":"crossref","first-page":"e3876","DOI":"10.1093\/cid\/ciaa1639","article-title":"Liquid biopsy for invasive mold infections in hematopoietic cell transplant recipients with pneumonia through next-generation sequencing of microbial cell-free DNA in plasma","volume":"73","author":"Hill","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2025.01.002_bib72","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s11908-013-0380-y","article-title":"Anti-aspergillus prophylaxis in lung transplantation: a systematic review and meta-analysis","volume":"15","author":"Bhaskaran","year":"2013","journal-title":"Curr Infect Dis Rep"},{"issue":"3","key":"10.1016\/j.idc.2025.01.002_bib73","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13832","article-title":"Antifungal prophylaxis in adult lung transplant recipients: uncertainty despite 30 years of experience. A systematic review of the literature and network meta-analysis","volume":"24","author":"Marinelli","year":"2022","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2025.01.002_bib74","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13333","article-title":"Antifungal prophylaxis in lung transplant recipients: a systematic review and meta-analysis","volume":"22","author":"Pennington","year":"2020","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2025.01.002_bib75","first-page":"122","article-title":"Strategies for the prevention of invasive fungal infections after lung transplant","volume":"7","author":"Bitterman","year":"2021","journal-title":"J\u00a0Fungi"},{"issue":"9","key":"10.1016\/j.idc.2025.01.002_bib76","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13544","article-title":"Invasive aspergillosis in solid-organ transplant recipients: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Husain","year":"2019","journal-title":"Clin Transplant"},{"issue":"1","key":"10.1016\/j.idc.2025.01.002_bib77","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/cid\/ciz156","article-title":"Invasive fungal infection after lung transplantation: epidemiology in the setting of antifungal prophylaxis","volume":"70","author":"Baker","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2025.01.002_bib78","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.healun.2016.01.007","article-title":"The 2015 International Society for Heart and Lung Transplantation Guidelines for the management of fungal infections in mechanical circulatory support and cardiothoracic organ transplant recipients: executive summary","volume":"35","author":"Husain","year":"2016","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"1","key":"10.1016\/j.idc.2025.01.002_bib79","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/ajt.12993","article-title":"Targeted versus universal antifungal prophylaxis among liver transplant recipients","volume":"15","author":"Eschenauer","year":"2015","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.idc.2025.01.002_bib80","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1111\/ajt.12963","article-title":"Randomized, double-blind trial of anidulafungin versus fluconazole for prophylaxis of invasive fungal infections in high-risk liver transplant recipients","volume":"14","author":"Winston","year":"2014","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.idc.2025.01.002_bib81","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/myc.13205","article-title":"Epidemiology of invasive fungal disease in haematologic patients","volume":"64","author":"Souza","year":"2021","journal-title":"Mycoses"},{"issue":"4","key":"10.1016\/j.idc.2025.01.002_bib82","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","author":"Cornely","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.idc.2025.01.002_bib83","first-page":"3221","article-title":"European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia","volume":"73","author":"Maertens","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.idc.2025.01.002_bib84","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1128\/AAC.01985-15","article-title":"Network meta-analysis and pharmacoeconomic evaluation of fluconazole, itraconazole, posaconazole, and voriconazole in invasive fungal infection prophylaxis","volume":"60","author":"Zhao","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.idc.2025.01.002_bib85","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/cid\/ciaa358","article-title":"Isavuconazole as primary antifungal prophylaxis in patients with acute myeloid leukemia or myelodysplastic syndrome: an open-label, prospective, phase 2 study","volume":"72","author":"Bose","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2025.01.002_bib86","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1093\/jac\/dkx133","article-title":"Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia","volume":"72","author":"Cornely","year":"2017","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.idc.2025.01.002_bib87","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1080\/10428194.2016.1204652","article-title":"Epidemiology of invasive fungal infections during induction therapy in adults with acute lymphoblastic leukemia: a GRAALL-2005 study","volume":"58","author":"Mariette","year":"2017","journal-title":"Leuk Lymphoma"},{"issue":"24","key":"10.1016\/j.idc.2025.01.002_bib88","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1182\/blood-2010-02-268151","article-title":"Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation","volume":"116","author":"Wingard","year":"2010","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.idc.2025.01.002_bib89","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/s41564-022-01172-2","article-title":"COVID-19-associated fungal infections","volume":"7","author":"Hoenigl","year":"2022","journal-title":"Nat Microbiol"},{"issue":"6","key":"10.1016\/j.idc.2025.01.002_bib90","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00134-021-06431-0","article-title":"Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial","volume":"47","author":"Vanderbeke","year":"2021","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.idc.2025.01.002_bib91","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s13054-021-03728-w","article-title":"Inhaled liposomal amphotericin-B as a prophylactic treatment for COVID-19-associated pulmonary aspergillosis\/aspergillus tracheobronchitis","volume":"25","author":"Van Ackerbroeck","year":"2021","journal-title":"Crit Care"},{"issue":"24","key":"10.1016\/j.idc.2025.01.002_bib92","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa021931","article-title":"Itraconazole to prevent fungal infections in chronic granulomatous disease","volume":"348","author":"Gallin","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.idc.2025.01.002_bib93","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the ESCMID-ECMM-ERS 2017 guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infection"},{"issue":"3","key":"10.1016\/j.idc.2025.01.002_bib94","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3324\/haematol.2016.152900","article-title":"ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients","volume":"102","author":"Tissot","year":"2017","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.idc.2025.01.002_bib95","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2025.01.002_bib96","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin b for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"10273","key":"10.1016\/j.idc.2025.01.002_bib97","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(21)00219-1","article-title":"Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial","volume":"397","author":"Maertens","year":"2021","journal-title":"Lancet"},{"issue":"10020","key":"10.1016\/j.idc.2025.01.002_bib98","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.idc.2025.01.002_bib102","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/M13-2508","article-title":"Combination antifungal therapy for invasive aspergillosis a randomized trial","volume":"162","author":"Marr","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.idc.2025.01.002_bib99","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dky463","article-title":"Variability and exposure-response relationships of isavuconazole plasma concentrations in the Phase 3 SECURE trial of patients with invasive mould diseases","author":"Kaindl","year":"2019","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.idc.2025.01.002_bib100","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/jac\/dkae037","article-title":"Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoring","volume":"79","author":"Mikulska","year":"2024","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"12","key":"10.1016\/j.idc.2025.01.002_bib101","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/myc.13653","article-title":"Clinical and demographic factors affecting trough levels of isavuconazole in critically ill patients with or without COVID-19","volume":"66","author":"Bertram","year":"2023","journal-title":"Mycoses"},{"issue":"5","key":"10.1016\/j.idc.2025.01.002_bib103","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1086\/590566","article-title":"Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: mycoses study group and european organization for research and treatment of cancer consensus criteria","volume":"47","author":"Segal","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2025.01.002_bib104","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.01141-23","article-title":"Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017\u20132021)","volume":"62","author":"Pfaller","year":"2024","journal-title":"J\u00a0Clin Microbiol"},{"issue":"6","key":"10.1016\/j.idc.2025.01.002_bib105","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3201\/eid2106.140717","article-title":"Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus","volume":"21","author":"van der Linden","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2025.01.002_bib106","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.3201\/eid1710.110226","article-title":"Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007\u20132009","volume":"17","author":"van der Linden","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2025.01.002_bib107","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jiac.2022.10.010","article-title":"Efficacy and safety of isavuconazole against deep-seated mycoses: a phase 3, randomized, open-label study in Japan","volume":"29","author":"Kohno","year":"2023","journal-title":"J\u00a0Infect Chemother"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552025000029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552025000029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T22:31:57Z","timestamp":1747175517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552025000029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":114,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0891552025000029"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2025.01.002","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Invasive Aspergillosis in the Current Era","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2025.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}